ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Decentralised trials dramatically transforming clinical research: ICON
Isaac Rodriguez-Chavez discusses the impact decentralised trials have had on the industry, and how that transformation is likely to continue.
Capture, curate, consume: The three Cs of managing data in decentralised and hybrid clinical trials
Emily Mitchell and Christina Dinger run through some of the most important elements of collating and organising data during clinical trials.
Combating antimicrobial resistance
Shelley McLendon, Vice President, Vaccines and Infectious Disease, discusses the use of novel diagnostics to help monitor for AMR outbreaks and reduce the overuse and misuse of antimicrobials.
ICON: Accellacare Site Network expansion
In this monthly snapshot of industry news, ICON’s expansion of its Accellacare Site Network is highlighted.
The ecosystem overtakes the producers in pharma and life sciences
This article discusses the substantial number of significant acquisitions and mergers in the pharma and life sciences industry, and features ICON’s $12bn acquisition of PRA Health Sciences back in February.
Recruiting patients to increase diversity & inclusion in clinical trials: one size does not fit all
More so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering momentum within the clinical trial community.
Forging ahead with French and Irish business connections
ICON is awarded the Best Irish Company in France 2021, recognising the significant contribution our French colleagues have made to our business in France and globally.
The growing potential of neurological biomarkers as surrogate endpoints for accelerated drug development
This article by Dr. Peter Schueler explores how digital and liquid biomarkers are developing, and how they can impact the future of neurological studies.
ICON expands Accellacare Site Network
An article reporting on ICON's recent announcement that its Accellacare Site Network has entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities.
ICON announces the expansion of its Accellacare site network
This article highlights the expansion of the Accellacare site network and how it will increase access and engagement with investigative sites and their patients.